Abstract:Tuberculosis (TB), one of the top ten causes of death globally induced by the infection of Mycobacterium tuberculosis (Mtb), remains a grave public health issue worldwide. With almost one-third of the world's population getting infected by Mtb, between 5% and 10% of these infected individuals are predicted to develop active TB disease, which would not only result in severe tissue damage and necrosis, but also pose serious threats to human life. However, the exact molecular mechanisms underlying the pathogenesis and immunology of TB remain unclear, which significantly restricts the effective control of TB epidemics. Despite significant advances in current detection technologies and treatments for TB, there are still no appropriate solutions that are suitable for simultaneous, early, rapid, and accurate screening of TB. Various cellular events can perturb the development and progression of TB, which are always associated with several specific molecular signaling events controlled by dysregulated gene expression patterns. Long non-coding RNAs (lncRNAs), a kind of non-coding RNA (ncRNA) with a transcript of more than 200 nucleotides in length in eukaryotic cells, have been found to regulate the expression of protein-coding genes that are involved in some critical signaling events, such as inflammatory, pathological, and immunological responses. Increasing evidence has claimed that lncRNAs might directly influence the susceptibility to TB, as well as the development and progression of TB. Therefore, lncRNAs have been widely expected to serve as promising molecular biomarkers and therapeutic targets for TB. In this review, we summarized the functions of lncRNAs and their regulatory roles in the development and progression of TB. More importantly, we widely discussed the potential of lncRNAs to act as TB biomarkers, which would offer new possibilities in novel diagnostic strategy exploration and benefit the control of the TB epidemic.

Research Progress of the Noncoding RNA of Mycobacteriumtuberculosis

Immune regulation and emerging roles of noncoding RNAs in Mycobacterium tuberculosis infection

The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection

[Research Progress in Non-Coding RNAs in Mediating Immune Responses of Macrophages to Mycobacterium Tuberculosis Infection].

Long Non-coding RNA Transcripts in Mycobacterium tuberculosis -Host Interactions

The Role of microRNAs and Long Non-Coding RNAs in the Regulation of the Immune Response to Mycobacterium tuberculosis Infection

Long Non-coding RNAs in Tuberculosis: From Immunity to Biomarkers

The role of non-coding RNA on macrophage modification in tuberculosis infection

Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?

Research Progress on Genetic Control of Host Susceptibility to Tuberculosis.

miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy

miRNAs in immune responses to Mycobacterium tuberculosis infection.

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.

Genomics of nontuberculous mycobacteria

Structural Basis of Mycobacterium Tuberculosis Transcription and Transcription Inhibition

Exosomal ncRNAs profiling of mycobacterial infection identified miRNA-185-5p as a novel biomarker for tuberculosis

Functions of exosomal non-coding RNAs to the infection with Mycobacterium tuberculosis

MicroRNAs As Immune Regulators and Biomarkers in Tuberculosis

Emerging advances in identifying signal transmission molecules involved in the interaction between Mycobacterium tuberculosis and the host

Recent Advances in Research on Molecular Detection for Resistance of Mycobacterium Tuberculosis

The Role of Mrna Alternative Splicing in Macrophages Infected with Mycobacterium Tuberculosis: A Field Needing to Be Discovered.